Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul/Aug;36(4):294-299.
doi: 10.1177/1043454219854983.

Consensus Recommendations From the Children's Oncology Group Nursing Discipline's State of the Science Symposium: Symptom Assessment During Childhood Cancer Treatment

Affiliations
Review

Consensus Recommendations From the Children's Oncology Group Nursing Discipline's State of the Science Symposium: Symptom Assessment During Childhood Cancer Treatment

Janice S Withycombe et al. J Pediatr Oncol Nurs. 2019 Jul/Aug.

Abstract

Background: Recognizing and addressing illness-related distress has long been a priority for pediatric oncology nurses and the Children's Oncology Group. Although symptoms are known to be highly prevalent during treatment for childhood cancer, there is currently no guidance for how often symptoms should be assessed, which symptoms should be prioritized for assessment, and how the data should be collected. Methods: The Nursing Discipline, within Children's Oncology Group, hosted a one-day Interprofessional seminar titled "Symptom Assessment During Childhood Cancer Treatment: State of the Science Symposium." Following the symposium, an expert panel was assembled to review all available evidence, including information presented and collected during the symposium. Consensus-building discussions were held to identify common themes and to produce recommendations for clinical practice. Results: Four recommendations emerged including (1) the identification of priority "core" symptoms for assessment; (2) inclusion of the child's voice through self-report, when possible; (3) consistent documentation and communication of symptom assessment results; and (4) implementation of patient/family education related to symptoms. Discussion: Symptom recognition, through appropriate assessment, is the first step in symptom management. The goal for developing and sharing these recommendations is to promote consistent and comparable clinical practice across institutions in regard to symptom assessment during childhood cancer therapy. Integration of these recommendations will set the stage for future studies related to the frequency of symptoms across disease groups, projection of anticipated symptom trajectories, development of evidence-based teaching tools for common symptoms, and evaluation of patient outcomes with enhanced symptom assessment and management.

Keywords: Children’s Oncology Group; consensus; pediatric oncology; symptom science.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

Cited by

References

    1. Baggott C., Dodd M., Kennedy C., Marina N., Matthay K. K., Cooper B. A., Miaskowski C. (2010). Changes in children’s reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy. Journal of Pediatric Oncology Nursing, 27, 307-315. doi:10.1177/1043454210377619 - DOI - PubMed
    1. Basch E., Deal A. M., Dueck A. C., Scher H. I., Kris M. G., Hudis C., Schrag D. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Journal of the American Medical Association, 318, 197-198. doi:10.1001/jama.2017.7156 - DOI - PMC - PubMed
    1. Basch E., Jia X., Heller G., Barz A., Sit L., Fruscione M., . . . Schrag D. (2009). Adverse symptom event reporting by patients vs. clinicians: Relationships with clinical outcomes. Journal of the National Cancer Institute, 101, 1624-1632. doi:10.1093/jnci/djp386 - DOI - PMC - PubMed
    1. Buckner T. W., Wang J., DeWalt D. A., Jacobs S., Reeve B. B., Hinds P. S. (2014). Patterns of symptoms and functional impairments in children with cancer. Pediatric Blood & Cancer, 61, 1282-1288. doi:10.1002/pbc.25029 - DOI - PMC - PubMed
    1. Graetz I., McKillop C. N., Stepanski E., Vidal G. A., Anderson J. N., Schwartzberg L. S. (2018). Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: A randomized controlled feasibility trial. Journal of Cancer Survivorship, 12, 431-440. doi:10.1007/s11764-018-0682-z - DOI - PMC - PubMed

Publication types

Substances